Determining the Optimal Use of Adjuvant Immunotherapy in Renal Cell Carcinoma OncLive, 19 Jun 2023 Benjamin Garmezy, MD Kidney and renal pelvis cancers are one of the 10 most common new malignant diagnoses in both men and…